The Deal Register
Database › Debt financing › ZYUS Life Sciences Corporation Announces Closing of Secured Loan and…

Debt financing

ZYUS Life Sciences Corporation Announces Closing of Secured Loan and Amendments to Prior Secured Promissory…

Lane
Debt financing
Announced
17 Oct 2025
Province
Saskatchewan
Industry
Healthcare & life sciences
Status
Announced
What the filing says
ZYUS Life Sciences Corporation (the " Company ") (TSXV: ZYUS ), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that an independent director of the Company (the " Director Lender ") has advanced a CA$1.5 million secured loan (the " Director Loan ") to ZYUS Life Sciences Inc., a wholly-owned subsidiary of the Company (" ZYUS Inc. "), which closed on October 16, 2025, (the " Loan ").
Terms stated
exercise price, interest rate, maturity date
Source

The terms are in the subscriber edition

This transaction carries 3 stated terms, with the value, unit and basis of each.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe